Straits Times Index
3,384.46 +0.17 (+0.01%) Nikkei
27,678.69 +169.23 (+0.62%) Hang Seng
21,280.03 -380.44 (-1.76%) FTSE 100
7,901.80 +81.64 (+1.04%) BTC-USD
22,781.47 -603.98 (-2.58%) CMC Crypto 200
523.00 -13.86 (-2.58%)
Amyris, Inc. (AMRS)
After hours:
| Previous close | 1.7500 |
| Open | 1.7000 |
| Bid | 0.0000 x 4000 |
| Ask | 0.0000 x 1300 |
| Day's range | 1.6684 - 1.7550 |
| 52-week range | 1.2500 - 5.3100 |
| Volume | |
| Avg. volume | 6,754,088 |
| Market cap | 617.936M |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3870 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.02 |
- Motley Fool
Why Amyris Stock Was Driven Into the Ground on Wednesday
Synthetic-biology company Amyris (NASDAQ: AMRS) had an absolutely awful day on the stock exchange Wednesday, due to an earnings report that fell well short of expectations. After market hours on Tuesday, Amyris divulged its third-quarter results. Alas, the total fell far short of the average analyst estimate of just under $112 million.
- Zacks
Amyris, Inc. (AMRS) Reports Q3 Loss, Misses Revenue Estimates
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -109.52% and 36.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Motley Fool
Why Amyris Stock Tumbled This Week
Amyris had a good news/bad news Tuesday, with the market deciding that the latter outweighed the former. The good was that three of the specialized biotech company's products will be included in the offerings of Sephora when the big cosmetics retailer launches its U.K. website. While having three out of the undoubtedly many Sephora products on the site isn't considerable and thus won't generate monster sales, being in that selection is indisputably a positive development for Amyris.
